Randomized trial, NIH funded
Semaglutide · 108 people · Better than the comparison · Placebo-controlled randomized trial
In HIV-associated lipohypertrophy, abdominal visceral fat fell 30.6% over 32 weeks against placebo. The authors want larger trials to check serious side effects.
Lancet Diabetes Endocrinol, 2024 (pubmed.ncbi.nlm.nih.gov/38964353)